FIA
EXAS

FNY Investment Advisers’s Exact Sciences EXAS Stock Holding History

FNY Investment Advisers’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-28,500
Closed -$2.89M – 882
2025
Q4 		$2.89M Buy
+28,500
New +$2.29M 0.82% 23
2019
Q4 		– Sell
-2,600
Closed -$234K – 880
2019
Q3 		$234K Buy
+2,600
New +$296K 0.07% 157
2019
Q1 		– Sell
-171
Closed -$10K – 765
2018
Q4 		$10K Buy
+171
New +$11.7K ﹤0.01% 419

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

FNY Investment Advisers's EXAS Position: Q1 2026 in Review

FNY Investment Advisers sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 28,500 shares — an estimated $2.89M sold.

FNY Investment Advisers first reported a position in EXAS in Q4 2018 and held it in 3 quarters. The position peaked at $2.89M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • FNY Investment Advisers reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • FNY Investment Advisers sold 28,500 Exact Sciences shares in Q1 2026, an estimated $2.89M.
  • FNY Investment Advisers first reported a position in Exact Sciences in Q4 2018 and held it in 3 quarters.
  • FNY Investment Advisers's Exact Sciences position peaked at $2.89M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on FNY Investment Advisers's 13F filing for Q1 2026, filed 15 Apr 2026.